This 2-hour online course offers a streamlined alternative to traditional 8-hour buprenorphine training, providing a fast and efficient way to equip prescribers with the knowledge needed to effectively treat patients with opioid use disorder.

This 45-minute, on-demand session from the ASAM 2022 Review Course provides an overview of the history of opioid use and opioid regulation, explores the neurobiology and pharmacology of opioids, and reviews treatment options for opioid use disorder and opioid withdrawal.

This 15.75-hour, on-demand course is the essential primer for physicians preparing for the addiction medicine examination and also serves to increase other healthcare professionals' knowledge of addiction.

This 35-minute, on-demand session from the ASAM 2025 Review Course covers a diverse group of substances including hallucinogens, dissociatives, inhalants, and steroids as well as the physiological effects, epidemiology, and treatment options.

This 50-minute, on-demand session from the ASAM 2025 Review Course provides an overview of the history of opioid use and opioid regulation, explores the neurobiology and pharmacology of opioids, and reviews treatment options for opioid use disorder and opioid withdrawal.

This 1.5-hour session recording is part of an online case-based learning collaborative series focused on building interprofessional teams.

This 1.5-hour, live-virtual course is part of an online case-based learning collaborative series focused on building interprofessional teams.

This one-hour, on-demand, journal article-based activity explores the use of buprenorphine to treat opioid use disorder while considering risks and potential disengagement. This article focuses on the transition to extended-release or long-acting buprenorphine to improve outcomes and treatment adherence.

This one-hour, on-demand, journal article-based activity examines the relationship between methadone dosing during the first week of treatment and 30-day treatment retention. This article addresses early dropout challenges and offers solutions to patients' adherence to treatment.

This one-hour, on-demand, journal article-based activity explores the rising US drug overdose death rate from 2002 to 2022, with a focus on the emerging role of kratom (mitragynine). Recent data on kratom detection in overdose cases provides consideration for how these findings can inform overdose prevention efforts and guide the development of targeted interventions.

This 1.5-hour session recording is part of an online case-based learning collaborative series focused on treating opioid use disorder.

This 1.5-hour session recording is part of the PCSS-MOUD learning collaborative series focused on caring for patients with co-occurring substance use disorders.